Aims/hypothesis Our earlier studies have established the role of 12/15-lipoxygenase (LO) in mediating the inflammatory reaction in diabetic retinopathy. However, the exact mechanism is still unclear. The goal of the current study was to identify the potential role of endoplasmic reticulum (ER) stress as a major cellular stress response in the 12/15-LO-induced retinal changes in diabetic retinopathy. Methods We used in vivo and in vitro approaches. For in vivo studies, experimental diabetes was induced in wild-type (WT) mice and 12/15-Lo (also known as Alox15) knockout mice (12/15-Lo −/− ); ER stress was then evaluated after 12-14 weeks of diabetes. We also tested the effect of intravitreal injection of 12-hydroxyeicosatetraenoic acid (HETE) on retinal ER stress in WT mice and in mice lacking the catalytic subunit of NADPH oxidase, encoded by Nox2 (also known as Cybb) (Nox2 −/− mice).
Introduction
Diabetic retinopathy is the leading cause of vision loss in the working-age population worldwide [1] . It is characterised by an early inflammatory response that leads to disruption of the blood retinal barrier. This ultimately leads to diabetic macular oedema and retinal neovascularisation [2] . The mechanism of diabetic retinopathy has not yet been completely elucidated and the current therapies are limited by several side effects. Therefore, there is a need to investigate the underlying mechanism of diabetic retinopathy that could lead to identification of new therapeutic targets [3] .
Upregulation of adhesion molecules and subsequent leucocyte adhesion to endothelial cells (leucostasis) play a crucial role in the pathogenesis of retinal hyperpermeability and neovascularisation in diabetic retinopathy [4, 5] . In addition to hyperglycaemia, dyslipidaemia and increased levels of bioactive lipids were considered major contributors to microvascular dysfunction seen in diabetic retinopathy [6] . 12/15 lipoxygenase (12/15-LO) is one of the lipoxygenase superfamily that incorporates two oxygen atoms at position 12 or 15 of arachidonic acid and related substrates, generating bioactive lipid metabolites [7] . Among these metabolites, 12-and 15-hydroxyeicosatetraenoic acids (HETEs) elicit pro-inflammatory and neutrophil chemotactic properties in various disease models [8, 9] including neuronal damage [10] and diabetic retinopathy [11] . Our previous studies showed significant increases in 12-and 15-HETE levels in the vitreous of individuals with diabetic retinopathy and in the retinas of Akita mice, a model of type 1 diabetes [12, 13] . In addition, we showed increased retinal permeability, inflammatory mediators such as intercellular adhesion molecule 1 (ICAM1) and vascular cell adhesion molecule 1 (VCAM1), and retinal neovascularisation in normal mice by intravitreal injection of 12-HETE [14] . In contrast, genetic deletion of 12/15-Lo (also known as Alox15) significantly reduced retinal permeability in diabetic mice and attenuated neovascularisation in the mouse model of oxygeninduced retinopathy [12, 15] . Consistent with our in vivo findings, inhibition of endothelial 12/15-LO in human retinal endothelial cells (HRECs) reduced high-glucoseinduced leucostasis and ICAM-1 expression [14] . These findings indicate that 12/15-LO plays a causal role in diabetic retinopathy; however, the underpinning mechanism is yet to be determined.
Endoplasmic reticulum (ER) is the cell organelle responsible for proper protein folding, calcium homeostasis and lipid biosynthesis. Growing evidence suggests that ER stress acts as a major sensor that regulates cell energy metabolism, inflammation, redox status and cell survival under diabetic conditions [16] [17] [18] [19] [20] . Earlier studies have linked 12/15-LO signalling with the ER stress response [21] . There are three branches of transducer proteins that recognise ER stress, triggering a cellular response known as the unfolded protein response (UPR): RNA-dependent protein kinase-like ER-regulated kinase (PERK), inositol-requiring enzyme 1 (IRE1) and activating transcription factor (ATF) 6 . Disturbance of any of the ER functions can trigger UPR. The first arm of UPR is the PERK pathway, which is initiated by PERK phosphorylation. Phospho-PERK inhibits phosphorylation of eukaryotic initiation factor 2 α (eIF2-α), which decreases the protein overload in the cell followed by the selective activation of ATF4. The second pathway of UPR includes IRE1, which homodimerises and trans-autophosphorylates; then, by using its endonuclease activity, it splices the mRNA of X-box binding protein 1 (XBP1) to form spliced XBP1 (XBP1s). ATF6 is the third signalling pathway in UPR. It is translocated to Golgi apparatus, where it is cleaved. Activation of UPR genes depends to a great extent on the duration of the insult and how long the cell is exposed to the stress. These pathways cause activation of transcription factors like ATF4, XBP1s or cleaved ATF6 to translocate to the nucleus, where they stimulate the transcription of UPR genes, such as calnexin and protein disulfide isomerase (PDI) [19] [20] [21] .
Several reports showed that oxidative stress, as well as the perturbation of calcium homeostasis and elevated levels of cytosolic calcium, contribute to ER stress in different disease models [22, 23] . Previously, we have demonstrated NADPH oxidase (NOX) to be a major source of oxidative stress in retinas of diabetic rodents and have also demonstrated the existence of a crosstalk between 12/15-LO and the NOX system both in vitro and in vivo [13, 15, 24] . However, the interplay between ER stress, NOX and calcium homeostasis in 12/15-LO-mediated microvascular dysfunction during diabetic retinopathy remains unclear.
The goal of the current study was to investigate how 12/15-LO mediates microvascular dysfunction in diabetic retinopathy by portraying its causal relationship with ER stress and calcium homeostasis. Furthermore, we aimed to characterise the crosstalk between the two stress-response pathways-ER stress and NOX-mediated oxidative stress-in 12/15-LO-induced microvascular dysfunction using both genetic and pharmacological approaches. 
Methods

Experimental animals
B6.129S-Cybb
tm 1D in /J; stock No: 002365, Jackson Laboratories) on C57BL/6J background. Diabetes was induced by intraperitoneal injection of streptozotocin (STZ) (Sigma, St Louis, MO, USA) at 50 mg/kg for 3-5 days until the mice developed diabetes (random blood glucose ≥13.9 mmol/l). Intravitreal injections were performed in non-diabetic mice as previously described using 12-HETE (Cayman Chemical, Ann Arbor, MI, USA) [25, 26] .
Culture of HRECs HRECs were purchased from Cell Systems Corporation (Kirkland, WA, USA) and were grown at 37°C under 5% CO 2 in Endothelial Basal Medium-2 (EBM-2) (Lonza, Walkersville, MD, USA) supplemented with 10% FBS (vol./vol.) (Atlantic Biological, Norcross, GA, USA) and 1% penicillin/streptomycin (vol./vol.) (Corning, Tewksbury, MA, USA). These cells were negative for mycoplasma and the majority were >95% positive for von Willebrand factor/factor VIII and CD31 (endothelial markers), whereas the contaminating astrocytes (stained with glial fibrillary acidic protein [GFAP] ) and pericytes (stained with neural/ glial antigen 2 [NG2]) were insignificant <1%. After HRECs reached 90% confluence, the medium was changed to be serum free, followed by different treatment with 15-HETE (0.1 μmol/l, Cayman Chemical) or vehicle (ethanol) in the presence or absence of 4-phenylbutyric acid (PBA, 30 μmol/l, Santa Cruz, Dallas, TX, USA), VAS2870 (10 μmol/l, Sigma), or apocynin (30 μmol/l, Calbiochem, La Jolla, CA, USA). Of note, species-specific divergence between orthologous LO isoforms has been reported for mouse 12-LO, which is arachidonate 15-LO in humans. This difference implies that caution should be taken if experimental data on LO activity are being translated from one species to others [27, 28] . Therefore, 12-HETE has been used in all mouse experiments while 15-HETE has been used in all human retinal endothelial cell culture experiments. The doses of 12-and 15-HETE were selected according to what was previously detected in the vitreous of individuals with diabetic retinopathy, 50 ng/ml (approximately 0.1-0.2 μmol/l) [12] .
Western blot analysis and immunoprecipitation Western blot analysis was conducted on retinal or cell lysates using antibodies for XBP1s, XBP1, p-PERK, PERK, p-eIF2α, eIF2α, ATF4, ATF6, PDI, gp91 phox , P47 phox , vascular endothelial growth factor receptor-2 (VEGFR2), β-actin and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (ESM Table 1 ) according to the previously described method [26] . To assess the phosphorylation of VEGFR2 in HRECs, immunoprecipitation was performed by the addition of an anti-VEGFR2 antibody and protein A agarose beads (Cell Signaling Technology, Beverly, MA, USA) per manufacturer's instructions. This was followed by immunoblotting using anti-phosphotyrosine-PY20 antibody (BD Transduction Laboratories, San Diego, CA, USA).
Quantitative real-time RNA PCR The mRNA levels of various ER stress markers were measured using TaqMan primers for Eif2a, Atf6, Chop (also known as Ddit3), Xbp1, Pdi (also known as Pdia3), calnexin and 18 s for mouse samples, or IRE1α, XBP1, PERK (also known as EIF2AK3), ATF4, ATF6, CHOP (also known as DDIT3), PDI (also known as PDIA2), BIP (also Representative western blots (c) and densitometry (d-k) of ER stress protein levels in retinas isolated from WT mice that received intravitreal injection of vehicle or 12-HETE (0.1 μmol/l). Data represent individual data points with means ± SEM; *p < 0.05, **p < 0.01, ***p < 0.001 known as HSPA5) and calnexin for HREC samples (ESM Table 2 ) according to the previously described method [14] .
ELISA Vascular endothelial growth factor (VEGF) level in HREC conditioned media was estimated using VEGF ELISA kits (R&D Systems, Minneapolis, MN, USA) per the manufacturer's instructions.
In vitro leucocyte adhesion assay This assay was done according to our previous procedure [15] where adherent leucocytes were counted under an inverted fluorescence microscope (excitation/emission = 480/520 nm).
Superoxide measurement using dihydroethidium HRECs were incubated with dihydroethidium (DHE) (20 μmol/l, Invitrogen, Eugene, OR, USA; catalogue no. D11347) in Earle's balanced salt solution (EBSS) for 30 min. The medium was then replaced by EBSS containing NADPH (100 μmol/l) as an enzyme substrate for NOX followed by 15-HETE treatment in the presence or absence of VAS2870 (NADPH oxidase inhibitor, 10 μmol/l, Sigma) or PBA (30 μmol/l, Santa Cruz). A microplate reader (BioTek Instruments, Winooski, VT, USA) was used to detect the fluorescence intensity at different time intervals. Statistical data analysis The results are expressed as means ± SEM. Differences among different experimental groups were assessed by one-way ANOVA or two-tailed t test. Results were considered significant for p < 0.05. (Fig. 1a) .
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Further evidence for the involvement of 12/15-LO in the induction of retinal ER stress was acquired from the second approach in which normal mice were injected intravitreally with the 12/15-LO-derived predominant murine metabolite 12-HETE. The effects of 12-HETE on retinal ER stress marker mRNA and proteins were examined by q-RT-PCR and western blot, respectively. Retinal levels of ER stress markers mRNA were upregulated 1 week after intravitreal injection of 12-HETE (0.1 μmol/l) including Eif2α (p < 0.01), calnexin (p < 0.05), Chop (p < 0.001) and Pdi (p = 0.06), compared with retinas of vehicle-injected animals (Fig. 1b) . Moreover, western blot analysis revealed marked increases in p-PERK/PERK (Fig. 1c, g ), PDI (Fig. 1c, j) and ATF4 (Fig. 1c, k ) levels in retinas of 12-HETE-injected mice compared with the vehicleinjected controls, suggesting a causal relationship between 12/ 15-LO and ER stress induction in diabetic retinopathy. 12/15-LO-induced endothelial dysfunction is ER-stress-dependent The aforementioned data provided a rationale to study in depth the direct relationship between 12/15-LO and ER stress in mediating endothelial dysfunction using HRECs. Initially, we sought to confirm whether 12/15-LO-derived bioactive lipids could induce ER stress in vitro in HRECs. For this purpose, HRECs were treated with 15-HETE (0.1 μmol/l) or vehicle and cell lysates were collected at different time points (1, 4 and 24 h ). Western blot analysis showed an increase in the levels of PDI by 15-HETE starting after 1 h of treatment and reached a significant difference after 4 h (Fig. 2a, b) . Concordantly, WB analyses for other ER stress markers (Fig. 2c) revealed that p-PERK/PERK (Fig. 2h) and ATF6 (Fig. 2j) showed significant increases in their levels compared with vehicletreated cells. RT-PCR array of ER stress genes was utilised to assess UPR activation in HRECs treated with 15-HETE for 3 h. There was a significant upregulation of CHOP by 15-HETE compared with the vehicle-treated group (p < 0.05) (Fig. 2k) .
To functionally evaluate the impact of ER stress on 15-HETE-mediated endothelial dysfunction, we tested the effect of ER stress inhibition on 15-HETE-induced leucostasis in HRECs. Initial studies were conducted to confirm the contribution of ER stress in endothelial-leucocyte interaction using tunicamycin (Sigma), a known ER stress inducer. HRECs were treated with tunicamycin (5 μg/ml) for 24 h before adding fluorescently labelled human leucocytes for 90 min, followed by washing to remove the non-adherent leucocytes. As shown in Fig. 3 , ER stress induction by tunicamycin led to To investigate the involvement of ER stress in 15-HETE-induced leucostasis, ER stress inhibitor (PBA, 30 μmol/l) was added to HRECs before 15-HETE treatment. PBA significantly reduced (p < 0.01) the number of adherent leucocytes induced by 15-HETE. At the concentration of PBA used, HREC viability was not affected (90 ± 6%) as assessed by (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) (MTT) assay, indicating that the decrease in the number of adherent leucocytes to 15-HETE-activated HRECs was due to the inhibition of ER stress, but not to cell death.
Crosstalk between NADPH oxidase and ER stress We previously reported that NADPH oxidase is implicated in 12/15-LOinduced retinal endothelial cell dysfunction [13, 15] . Here, the crosstalk between NADPH oxidase and ER stress in 12/15-LO-induced retinal microvascular dysfunction was also examined. HRECs were treated with 15-HETE with or without the NADPH oxidase inhibitor apocynin (30 μmol/l). The ER stress marker PDI was upregulated by 15-HETE in the presence or absence of apocynin (p = 0.008 vs control) (Fig. 4a, b) . On the contrary, ER stress inhibition with PBA significantly reduced 15-HETE-induced expression of NOX2 (Fig. 4c, d ) and P47 phox (Fig. 4e, f) , which are the catalytic and regulatory subunits of NADPH oxidase, respectively. Furthermore, 15-HETE significantly increased superoxide production after 15 min (p < 0.001) and 30 min (p < 0.01) vs control that declined at 45 min. ER stress inhibition by PBA significantly reduced 15-HETE-induced superoxide production (p < 0.05 vs 15-HETE treated HRECs) and this effect was comparable to the effect of NADPH oxidase inhibition (Fig. 4g) . This proof of concept was then extended to be tested in vivo using Nox2 −/− mice. Non-diabetic Nox2 −/− mice were injected intravitreally with 12-HETE (0.1 μmol/l). One week after the injection, retinas were collected and both q-RT-PCR and western blotting were performed to screen the changes in retinal levels of ER stress genes and proteins, respectively. significantly upregulated protein levels of retinal PDI (Fig. 5b,  c) (p = 0.03 vs vehicle-injected) and ATF4 (Fig. 5b, d) -detecting dye followed by adding vehicle (ESM Video 1) or 15-HETE (0.1 μmol/l) (ESM Video 2). Real-time imaging showed a marked increase in the level of cytosolic calcium after adding 15-HETE compared with the control group. The ability of 15-HETE to induce intracellular calcium release may underscore a possible mechanism for 12/15-LOinduced ER stress (Fig. 6 ).
Intravitreal injection of 12-HETE in
Inhibition of ER stress attenuates 15-HETE-induced VEGFR2 phosphorylation
We measured VEGF levels in the supernatant of HRECs treated with 15-HETE or vehicle. 15-HETE had no effect on VEGF release from HRECs when compared with that of the vehicle-treated group (n = 4, p > 0.05) (Fig. 7a) . We previously showed that inhibition of NADPH oxidase reduced VEGFR2 phosphorylation in retinal endothelial cells treated with 12/15-LO-derived metabolites [13] . To investigate whether ER stress inhibition elicits a similar effect, HRECs were treated with 15-HETE for 5 min in the presence or absence of PBA (30 μmol/l), then immunoprecipitation was used to detect VEGFR2 phosphorylation (Fig. 7b) . 15-HETE induced VEGFR2-phosphorylation (p < 0.05), which was significantly reduced by the ER stress inhibitor (PBA) and the NADPH oxidase inhibitor (apocynin) (n = 4, p < 0.05) (Fig. 7c) . These data suggest that ER stress could play a role in 12/15-LO-induced retinal microvascular complications via activation of VEGFR2 signalling.
Discussion
Our previous studies established 12/15-LO as a potential player in the development of microvascular dysfunction in diabetic retinopathy via activating NADPH oxidase and VEGFR2 signalling [13, 15] . The current study explored the role of ER stress in mediating the effect of 12/15-LO lipid metabolites on retinal endothelial dysfunction during diabetic retinopathy. Our major findings include: (1) deletion of 12/15-Lo significantly attenuated the diabetes-induced ER stress in mouse retina; (2) 15-HETE, the major product of 12/15-LO in humans, induced ER stress in HRECs; (3) inhibition of ER stress reduced 15-HETE-induced leucocyte adhesion; (4) inhibition of NADPH oxidase or deletion of its catalytic subunit NOX2 did not reduce 12/15-LO-induced ER stress; (5) inhibition of ER stress reduced NADPH oxidase activity and expression of its catalytic and regulatory subunits NOX2 and P47 phox , respectively; (6) 15-HETE induced an increase in intracellular calcium levels in HRECs; (7) inhibition of ER stress reduced 15-HETE-induced VEGFR2 phosphorylation.
Accumulated evidence demonstrated that ER stress is a crucial player in the development of retinal microvascular dysfunction in diabetic retinopathy [19, 20] . However, the implication of ER stress in 12/15-LO-mediated retinal endothelial cell activation has not been investigated yet. The current study portrays a mechanistic axis that links hyperglycaemia to retinal endothelial cell dysfunction. This axis starts from hyperglycaemiainduced activation of 12/15-LO, followed by ER stress and NADPH oxidase activation, and ends with increased VEGFR2 phosphorylation. Consistent with previous reports, our in vivo experiments showed that diabetes induces ER stress in mouse retina [16] We also used an in vitro model utilising HRECs treated with 15-HETE and we detected activation of the ER stress response by 15-HETE. Lipoxygenases catalyse oxygen insertion into polyunsaturated fatty acids. There are different LO analogues such as 5-LO, 12-LO and 15-LO. The different numbers indicate the carbon at which the oxygen is added. Interestingly, a previous study reported that deletion of 5-or 12/15-Lo dampens diabetes-induced leucostasis after 3 months of diabetes. However, 5-Lo deletion only reduced capillary degeneration after 9 months of diabetes, suggesting a differential role for each enzyme at different stages of diabetic retinopathy [11] . Our data showed that ER stress inhibition significantly reduced 15-HETE-induced leucostasis in HRECs, suggesting the early involvement of ER stress in the 12/15-LO-induced inflammatory reaction.
Others have reported the presence of interaction between ER and oxidative stresses in endothelial cell dysfunction. Recently, mRNA-sequencing data showed ER stress-induced downregulation of endogenous antioxidant genes [29] . Also, ER stress induces endothelial dysfunction via NADPH oxidase. This notion has been supported by studies done both in vitro utilising primary coronary endothelial cells and in vivo using p47 phox−/− mice injected with tunicamycin [30] . We previously reported that 12/15-LO induced retinal microvascular complications in an NADPH-oxidasedependent mechanism [13, 15] . In the current study, we looked at the relationship between ER stress and NADPH oxidase in retinal endothelial cell dysfunction induced by 12/15-LO-derived metabolites. 12/15-LO-derived bioactive lipids induced ER stress despite the deletion or inhibition of NADPH oxidase, suggesting that either ER stress and NADPH oxidase are working independently, or ER stress is an upstream effector of NADPH oxidase. To uncover which of these two possibilities is involved, we measured superoxide production and the expression of NADPH oxidase subunits, NOX2 and P47 phox in HRECs after 15-HETE treatment in the presence or absence of a ER stress inhibitor. ER stress inhibition significantly reduced 15-HETE-induced superoxide production and expression of NOX2, and P47 phox in HRECs subjected to 15-HETE treatment. These findings suggest that ER stress is an upstream effector of NADPH oxidase in the signalling pathway induced by activated retinal 12/15-LO in diabetes.
PDI has been suggested as an organiser of NADPH oxidase activation in leucocytes [31] , vascular smooth muscles and endothelial cells [32, 33] . 12/15-LO-derived lipid metabolites increased levels of PDI in HRECs and mouse retina, which was not abrogated by either inhibition or deletion of NOX2. Moreover, diabetes-induced PDI upregulation was reduced in diabetic 12/15-LO −/− mouse retina. Interestingly, it was shown that PDI is associated with NADPH oxidase and acts as a redoxdependent enzyme complex regulator with a supportive effect on the activity of NADPH oxidase [31] . Thus, the ability of 12/15-LO-derived bioactive lipids to upregulate PDI both in vitro and in vivo suggests a mechanistic link between 12/15-LO-induced ER stress and NADPH oxidase activation during diabetic retinopathy.
It was reported that disruption of both lipid metabolism and calcium homeostasis causes activation of ER stress in the liver [23] . Moreover, thapsigargin, a widely used drug for ER stress induction, is an inhibitor of the sarco/endoplasmic reticulum Ca 2+ ATPase (SERCA), leading to elevated intracellular cytosolic Ca 2+ levels and induction of ER stress [34] . In obesity, it was reported that lipids inhibit SERCA and cause disturbance of Ca 2+ homeostasis with subsequent activation of ER stress [23] , which might be a possible mechanism of 12/15-LOinduced ER stress. In addition, the role of NOX2 in ER stress-oxidative stress interplay is Ca 2+ dependent [35, 36] . We reported in this study the 12/15-LO-induced upregulation of ATF4. Interestingly, ATF4 is not only involved in ER stress-induced oxidative stress [29] , but in addition, ATF4 binds to the promoter of human VEGF and upregulates both VEGF and cytokine production in retinas of diabetic rodents. Recently, ATF4 was reported to have a critical role in the regulation of the inflammatory response in brain and retinal endothelial cells [18, 37, 38] . The role of ER stress in diabetic retinopathy has been also linked to activation of VEGF signalling [17, 38, 39] . The link between ER stress and VEGF is supported by other reports that ER stress inhibition reduces VEGF expression in retinas of diabetic mice [16] . On the other hand, VEGF activates ER stress signalling in endothelial cells independent of the accumulation of misfolded proteins within the ER lumen [40] , suggesting that both ER stress and VEGF have positive feedback. Taking together the accumulated evidence of ER stress-VEGF crosstalk, and our previous study [13] , which demonstrated activation of VEGFR2 in retinal endothelial cells by 12/15-LO-derived metabolites, we examined whether ER stress is involved in activating VEGF signalling by 12/15-LO metabolites. Consistent with our previous report [13] , our data showed that, while 15-HETE has no effect on VEGF expression in HRECs, it significantly activated VEGFR2. This effect was significantly attenuated by PBA and apocynin, the ER stress and NADPH oxidase inhibitors, respectively. These data support the potential role of both ER stress and NADPH oxidase in mediating the effect of 15-HETE on retinal endothelial function via activating VEGF signalling.
The ubiquitin-proteasome system (UPS) is an important member of the protein quality control machinery [41, 42] . UPS dysfunction is implicated in ER stress-induced apoptosis [43] , oxidative stress induction [44, 45] , disturbed calcium homeostasis [46] and retinal diseases including diabetic retinopathy [47] . Recently, defective UPS Fig. 8 A schematic summary. Hyperglycaemia increases the activity of 12/15-LO enzyme with a subsequent increase of its bioactive lipid products, 12-and 15-HETE, in retinal endothelial cells. 12/15-LO lipid metabolites increase endothelial intracellular calcium levels that may activate ER stress and, in turn, NADPH oxidase. These intracellular activated pathways lead to increased phosphorylation of VEGFR2 and subsequent retinal endothelial dysfunction was reported to cause ER stress in diabetic retina [48] . However, other studies showed that ER stress itself can cause defective UPS [49] . The discrepancy noticed in RNA and protein levels of ER stress markers can be explained in part through disturbed UPS. Studying the impact of 12/15-LO on UPS may provide new insights into the mechanism of 12/15-LO-induced ER stress.
In summary, our previous and current data suggest that 12/ 15-LO is implicated in retinal microvascular dysfunction in diabetic retinopathy via activation of the ER stress/NADPH oxidase/VEGFR2 signalling pathway, and that disruption of Ca 2+ homeostasis could be an essential step in initiating this signalling pathway (Fig. 8) . Thus, the 12/15-LO/ER stress signalling loop may represent an early player that could be targeted to prevent progression of microvascular dysfunction in diabetic retinopathy.
